ReviewFrontiers in medicine2026

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis.

Jiang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.